Search results
Adaptimmune Therapeutics PLC (ADAP) Loses -28.34% in 4 Weeks, Here's Why a Trend Reversal May be...
Zacks via Yahoo Finance· 6 months agoAdaptimmune Therapeutics PLC (ADAP) is technically in oversold territory now, so the heavy selling...
Adaptimmune (ADAP) Rises as GSK Transfers T-Cell Therapy IND
Zacks via Yahoo Finance· 5 months agoAdaptimmune (ADAP) shares rise as GSK transfers IND for letetresgene autoluecel (lete-cel), which is...
Adaptimmune (ADAP) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 9 months agoAdaptimmune (ADAP) is expected to provide regulatory and developmental updates on its pipeline...
Hedge funds investors may adopt severe steps after Adaptimmune Therapeutics plc's (NASDAQ:ADAP)...
Simply Wall St. via Yahoo Finance· 1 year agoEvery investor in Adaptimmune Therapeutics plc (NASDAQ:ADAP) should be aware of the most powerful...
Adaptimmune Therapeutics (NASDAQ:ADAP shareholders incur further losses as stock declines 22% this...
Simply Wall St. via Yahoo Finance· 4 months agoThis month, we saw the Adaptimmune Therapeutics plc (NASDAQ:ADAP) up an impressive 58%. But only the...
Shareholders in Adaptimmune Therapeutics (NASDAQ:ADAP) are in the red if they invested five years...
Simply Wall St. via Yahoo Finance· 2 years agoAdaptimmune Therapeutics plc (NASDAQ:ADAP) shareholders should be happy to see the share price up...
Investors in Adaptimmune Therapeutics (NASDAQ:ADAP) from five years ago are still down 90%, even...
Simply Wall St. via Yahoo Finance· 10 months agoIt's nice to see the Adaptimmune Therapeutics plc (NASDAQ:ADAP) share price up 12% in a week. But...
What Kind Of Investors Own Most Of Adaptimmune Therapeutics plc (NASDAQ:ADAP)?
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls Adaptimmune Therapeutics plc (NASDAQ:ADAP), then you'll have...
Adaptimmune (ADAP) Surges More Than 80% in a Month: Here's Why
Zacks via Yahoo Finance· 4 months agoAdaptimmune (ADAP) surges on the completion of the rolling submission, with the FDA seeking approval...
Forecast: Analysts Think Adaptimmune Therapeutics plc's (NASDAQ:ADAP) Business Prospects Have...
Simply Wall St. via Yahoo Finance· 6 months agoCelebrations may be in order for Adaptimmune Therapeutics plc (NASDAQ:ADAP) shareholders, with the...